19 December 2018
: Case report
A Case of Undifferentiated Sarcoma in the Superior Vena Cava and Bilateral Cervical Veins
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Hiroshi Kobayashi1ABEFG*, Yuka Kobayashi2ABCD, Sho Yuasa3ABC, Masayuki Okabe3ABDG, Yuichi Yamada4BCDE, Yoshinao Oda4BCDE, Maria Debiec-Rychter5BCDE, Brian P. Rubin6ACDE, Toshimitsu Suzuki1ACDGDOI: 10.12659/AJCR.911659
Am J Case Rep 2018; 19:1507-1514
Abstract
BACKGROUND: Intimal sarcoma (IS) is a malignant mesenchymal tumor with predominantly intraluminal growth in large vessels and the heart. Due to the rarity of cases it often poses diagnostic problems in clinical and pathological settings. Although the classification of IS is still controversial, undifferentiated type of IS has recently been found to show immunohistochemical positivity with MDM2, CDK4, or PDGFRA and amplification of MDM2/CDK4 and PDGFRA.
CASE REPORT: The patient was a 76 years-old Japanese man who presented with superior vena cava (SVC) syndrome. CT identified a tumor or thrombi in the SVC, bilateral brachiocephalic, and jugular veins. The histology of the biopsy specimen revealed an undifferentiated tumor without immunohistochemical positivity for all antibodies available except vimentin and smooth muscle actin. He was treated conservatively and died of respiratory failure 2 months after presentation. At autopsy, the large veins were filled by a sausage-like tumor and the cut sections revealed hemorrhagic and necrotic tumor. The tumor cells were negative with MDM2, CDK4, and PDGFRA by immunohistochemistry. Amplification of MDM2 and PDGFRA was not identified by fluorescence in-situ hybridization.
CONCLUSIONS: We concluded that the case was an undifferentiated sarcoma (IS without any specific phenotype) arising in the SVC, bilateral brachiocephalic, and jugular veins. We propose a way of subtyping sarcomas with predominantly intraluminal growth in large vessels and the heart based on immunohistochemistry and amplification of MDM2 and PDGFRA. However, proper subtyping of these sarcomas requires further study.
Keywords: Blood Vessels, Hemangiosarcoma, Immunohistochemistry, In Situ Hybridization, Fluorescence, Jugular Veins, Vena Cava, Superior
SARS-CoV-2/COVID-19
11 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
09 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937505
29 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
In Press
17 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936537
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937511
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937598
16 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936743
Most Viewed Current Articles
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399